Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Melasma, Melasma (Facial Melasma). Basic parameters: from 25 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aims to gather expert opinions on the best ways to treat and manage melasma, a common skin condition characterized by dark patches on the face. Using a method called the Delphi Method, a group of dermatologists and other specialists will participate in several rounds of surveys to share their insights and reach a consensus on the most effective treatments and management strategies. The goal is to create a set of evidence-based guidelines that can help doctors provide more consistent, effective care for patients with melasma. The study will ensure that all experts' opinions are anonymous, and the results will be shared to improve treatment practices worldwide.
Detailed description
This study is designed to establish expert consensus on the management and treatment of melasma through a Delphi Method approach. The Delphi Method is a structured, iterative process where a panel of specialists-primarily dermatologists and other healthcare professionals experienced in treating melasma-will be asked to respond to a series of surveys. These surveys will allow experts to share their opinions on the most effective treatments, diagnostic criteria, and management strategies for melasma.
The study will be conducted in multiple rounds:
Round 1: Experts will provide open-ended feedback on their experiences and perspectives on melasma treatment.
Round 2: Based on the responses from Round 1, a refined set of questions will be circulated to clarify or expand on the issues raised.
Round 3: A final round will help refine and solidify the consensus on treatment approaches and care protocols.
The experts' feedback will be anonymized to ensure unbiased responses, and each round will be followed by analysis to identify areas of agreement and disagreement. The goal is to achieve a high level of consensus (usually around 70%) on key treatment recommendations and best practices for managing melasma.
This process will result in evidence-based guidelines for melasma treatment that healthcare providers can use to standardize care and improve patient outcomes. These guidelines will help address the variability in treatment practices and ensure that patients receive the most effective and up-to-date care based on expert consensus.
Primary outcome measures
- Consensus on Diagnostic & therapeutic Criteria for Melasma [Time frame: 6-12 weeks]
Eligibility criteria
Inclusion criteria
- Board-certified or equivalent dermatologist,
- Minimum of 5 years of post-certification clinical experience in the management of MELASMA,
- Willingness to participate in all Delphi rounds.
Exclusion criteria
- Inability or unwillingness to complete Delphi rounds.
- Lack of clinical experience with MELASMA
- Industry representatives without direct clinical practice
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Egypt · 1 center
- Venus Research Center — Cairo
Identifiers
NCT: NCT07296549 · Melasma Consensus